As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
The New England Journal of Medicine, pp. 1877-1887, 2018.
Abstract Background Patients with mild asthma often rely on inhaled short-acting β2-agonists for symptom relief and have poor adherence to maintenance therapy. Another approach might be for patients to receive a fast-acting reliever plus an inhaled glucocorticoid component on an as-needed basis to address symptoms and exacerbation risk. M...More